Install
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
- 913articles · 365d
- 2+ hour agolatest article
- Sep 14, 2025earliest in window
- 95%with images
- 285avg words
- HTH 573
- BI 538
- economy business and finance 451
- HW 337
- health 267
- FIB 254
- science and technology 156
- SCT 42
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Branding's Hidden Power | PharmExec
4+ mon, 3+ week ago (59+ words) Part of a wider Pharm Exec podcast discussion on brand-strategy leadership in the life sciences, Andy Milligan, founding partner of The Caffeine Partnership, notes the untapped resource and potential he believes strong organizational brands are missing out on: talent acquisition…...
Pharmaceutical Executive Daily: Pharma Industry's AI Adoption
6+ mon, 1+ week ago (316+ words) Pharma Industry's AI Adoption | PharmExec Pharmaceutical Executive Pharmaceutical Executive Daily: Pharma Industry's AI Adoption In today’s Pharmaceutical Executive Daily, Antengene and UCB enter a billion-dollar global licensing agreement for a bispecific T-cell engager, Teva signs a $400 million strategic growth capital…...
Why Patient Care is the Heart of Pharma Business | PharmExec
4+ mon, 1+ week ago (49+ words) Why Patient Care is the Heart of Pharma Business(1) Pharmaceutical Executive Using a Customer-Based Process to Synchronize Sales & Marketing Organizations in Pharma BMS vs. Moderna vs. Pfizer: The RNA Platform Race Pharmaceutical Executive Daily: FDA Approves Auvelity Pharmaceutical Executive Daily:…...
Technological Renaissance: AI’s Integration into the Pharmaceutical Industry
6+ mon, 1+ week ago (1168+ words) As AI rapidly reshapes drug development and clinical operations, industry leaders say transparency, governance, and strong data foundations will determine whether the technology accelerates innovation or stalls under regulatory and operational pressure. Artificial intelligence, once viewed as a distant promise…...
From Dashboards to Decisions: How AI Is Reshaping Pharma Brand Strategy
3+ mon, 3+ day ago (534+ words) AI-powered data analytics has evolved from a supporting function into the backbone of modern brand strategy and decision-making. The Questions You Couldn’t Ask in Time: How Agentic AI Accelerates Market Entry Agentic AI and the Future of Commercial Excellence in…...
What is Shadow AI and How is it Impacting Pharma Companies?
5+ mon, 4+ week ago (573+ words) Aravo CCO Dave Rusher discusses the risk of third-party AI usage at pharma companies. While the AI story continues to unfold across the pharma industry, one aspect may be causing more issues than solutions. Dave Rusher, CCO at Aravo, joined…...
Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B
4+ day, 1+ hour ago (83+ words) Moonwalk Biosciences' $70 Million Series B | PharmExec Pharmaceutical Executive Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks…...
Data and Trust
5+ mon, 3+ week ago (153+ words) A more thoughtful — and "unified" — model is emerging in consent-driven marketing in pharma. Personalization has perhaps been one of pharma marketing’s favorite buzzwords for years. But as Kevin King, a partner at Credera, makes clear in a guest column in…...
Unlocking the Future of Real-World Data & Research | PharmExec
3+ day, 15+ hour ago (40+ words) Unlocking the Future of Real-World Data & Research Pharmaceutical Executive Pharmaceutical Executive Daily: Moonwalk Biosciences' $70 Million Series B Trusted Research Environments Are Reshaping Real-World Data Access: Q&A with Mark Cziraky FDA Approves Zanvastro for Alexander Disease in Pediatrics & Adults...
How Are Automation and AI Impacting the Timeline From Prescription to Starting Treatment?
5+ mon, 3+ week ago (139+ words) Pharmaceutical Executive In a conversation with Pharmaceutical Executive, Shivani Patel, Senior Director of Business Development at ConnectiveRx, discusses how manufacturers are rethinking patient assistance program architecture amid the economic pressures of the Inflation Reduction Act (IRA). Patel explores how automation…...